Microbial and non-microbial factors often cause udder tissue stress. When this happens, it results in a loss of tissue functionality and productivity.
Intramammary infections can exploit this condition, further damaging the udder tissue.
Observable and detectable signs of mastitis will alert us to the problem, and milk cultures will guide us toward suitable therapies.
Typically, we seek solutions that kill bacteria – pre and post dipping products as prevention, and antibiotics to cure mastitis. But these solutions can also cause added stress to tissue health.
But what if we could help additionally protect the udder tissue?
Obviously, once udder tissue is damaged, there is a reduction in the quantity and activity of epithelial cells, and a decrease in milk production follows.
Once infected, bacteria can further harm the tissue with specific compounds.
Immune response stimulates a massive migration of somatic cells toward the mammary gland, breaking down the blood-milk barrier. Defensive cells respond by releasing reactive oxygen molecules and enzymes. All this is more stress.
Alterations in milk, including somatic cell counts1, reflect the degree of this physical damage.
Udder tissue needs time to regenerate autonomously to restore its functions. If it does not, the worst-case scenario described above can lead to challenging issues at the udder level.
Therefore, protecting udder tissue at the very first sign of possible mastitis (high SCC) is a must, but how?
An innovative, prompt, and versatile solution is OZOLEA-MAST.
OZOLEA-MAST was created by a team of researchers who are first, and foremost, dairy farmers.
As dairy farmers, they knew that if prompt action could be taken at the first signs of mastitis, many problems, including mastitis could be reduced or even prevented. And, they also understood first hand, how not discarding milk due to withdrawal was important to a dairy farmer’s profit.
It is not “just” wasted milk, but also the time and money in labor and inputs being lost.
OZOLEA-MAST is an animal device that does not contain active substances. It also fits FDA’s rules2 and does not need Pre-Market Approval.
So, how does it work? It supports tissue functionality by creating a film barrier in contact with the inner wall of the teat canal. This barrier generates a hostile environment for bacteria, and helps protect the tissue from external factors, thus allowing a natural regeneration3.
OZOLEA-MAST is also versatile and can be applied for a number of udder issues. Dealing with chronically high SCC4? Just detected milk flakes and want to act quickly with confidence? Would like to boost the efficacy of the ongoing antibiotic therapy?
These and more can be helped because Ozolea’s team thought big and developed several protocols for specific udder related challenges so that customers could get the most and best out of using OZOLEA-MAST for multiple needs. And, usage benefits the entire dairy supply chain, including consumers.
Please contact us to receive a complete OZOLEA-MAST product brochure to learn how each protocol can help you solve udder related issues: americas@ozolea.it
1 P.L. Ruegg, J.C.F. Pantoja Understanding and using somatic cell counts to improve milk quality, 2013, Irish Journal of Agricultural and Food Research 52: 101-117, 2013.
2 You can check details about How FDA Regulates Animal Devices here.
4 OZOLEA discussed this issue in “Dealing with chronically high SCC in lactating cows” in a previous guest blog.
